Page last updated: 2024-08-22

3,3'-diselenodipropionic acid and Cancer of Skin

3,3'-diselenodipropionic acid has been researched along with Cancer of Skin in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cao, W; Chen, T; Li, X; Wong, YS; Zheng, S; Zheng, W1

Other Studies

1 other study(ies) available for 3,3'-diselenodipropionic acid and Cancer of Skin

ArticleYear
Selenocysteine derivative overcomes TRAIL resistance in melanoma cells: evidence for ROS-dependent synergism and signaling crosstalk.
    Oncotarget, 2014, Sep-15, Volume: 5, Issue:17

    Topics: Antineoplastic Agents; Antioxidants; Apoptosis; Blotting, Western; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Synergism; Humans; In Situ Nick-End Labeling; Melanoma; Propionates; Reactive Oxygen Species; Receptor Cross-Talk; RNA Interference; Selenium Compounds; Skin Neoplasms; TNF-Related Apoptosis-Inducing Ligand

2014